Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: ARHGAP10 inhibits the epithelial–mesenchymal transition of non-small cell lung cancer by inactivating PI3K/Akt/GSK3β signaling pathway

Fig. 1

ARHGAP10 expression in NSCLC tissues. a ARHGAP10 was downregulated in NSCLC tissues compared with the normal tissues in Oncomine dataset. b Relative protein expression of ARHGAP10 in NSCLC tissues (n = 66) compared with adjacent non-tumor tissues (n = 66) with immunohistochemistry. c IHC scores of ARHGAP10 staining in NSCLC clinical stage. d Kaplan–Meier survival analysis about ARHGAP10 expression on 1144 NSCLC patients originated from TCGA. (*p < 0.05; ****p < 0.0001)

Back to article page